BFEC
CLVS

Benjamin F. Edwards & Company’s Clovis Oncology, Inc. CLVS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-46,800
Closed -$209K – 1794
2021
Q3 		$209K Sell
46,800
-42,800
-48% -$206K 0.01% 643
2021
Q2 		$520K Sell
89,600
-5,380
-6% -$31.5K 0.03% 441
2021
Q1 		$667K Buy
+94,980
New +$637K 0.04% 406
2015
Q1 		– Sell
-100
Closed -$6K – 1168
2014
Q4 		$6K Buy
+100
New +$5.26K ﹤0.01% 882

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Benjamin F. Edwards & Company's CLVS Position: Q4 2021 in Review

Benjamin F. Edwards & Company sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 46,800 shares — an estimated $209K sold.

Benjamin F. Edwards & Company first reported a position in CLVS in Q4 2014 and held it in 4 quarters. The position peaked at $667K in Q1 2021. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Benjamin F. Edwards & Company reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 46,800 Clovis Oncology, Inc. shares in Q4 2021, an estimated $209K.
  • Benjamin F. Edwards & Company first reported a position in Clovis Oncology, Inc. in Q4 2014 and held it in 4 quarters.
  • Benjamin F. Edwards & Company's Clovis Oncology, Inc. position peaked at $667K in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2021, filed 7 Feb 2022.